Control of total afucosylated glycoforms of antibodies produced in cell culture

AU2023285706B2Pending Publication Date: 2026-07-23AMGEN INC
View PDF 3 Cites 0 Cited by

Patent Information

Authority / Receiving Office
AU · AU
Patent Type
Applications
Current Assignee / Owner
AMGEN INC
Filing Date
2023-12-18
Publication Date
2026-07-23

Smart Images

  • Figure 00000049_0000
    Figure 00000049_0000
  • Figure 00000050_0000
    Figure 00000050_0000
  • Figure 00000051_0000
    Figure 00000051_0000
Patent Text Reader

Abstract

Provided herein are methods of modulating the levels of total afucosylated (TAF) glycoforms of a recombinant glycosylated protein produced by glycosylation-competent cells in a cell culture. In exemplary embodiments, the methods comprise maintaining the cell culture at an initial set point pH for an initial cell culture period. Related compositions comprising glycosylated proteins and TAF glycoforms thereof are also provided herein. 20 23 28 57 06 18 D ec 2 02 3 A B S T R A C T 2 0 2 3 2 8 5 7 0 6 1 8 D e c 2 0 2 3
Need to check novelty before this filing date? Find Prior Art